Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironment
- DOI
- 10.1158/1535-7163.mct-25-1492
- Published
- 2026-11-03
- Container
- Molecular Cancer Therapeutics
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/1535-7163.mct-25-1492,
title = {Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironment},
author = {Peter W. Janes and Mary E. Vail and Stacey Allen and Sakshi Arora and Zhipeng Cao and Tomohiro Fujii and Yutaka Matsuda and Fiona Chionh and Fiona E. Scott and Cameron Durrant and Andrew M. Scott},
year = {2026},
journal = {Molecular Cancer Therapeutics},
doi = {10.1158/1535-7163.mct-25-1492},
url = {https://doi.org/10.1158/1535-7163.mct-25-1492}
}RIS
TY - JOUR TI - Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironment AU - Peter W. Janes AU - Mary E. Vail AU - Stacey Allen AU - Sakshi Arora AU - Zhipeng Cao AU - Tomohiro Fujii AU - Yutaka Matsuda AU - Fiona Chionh AU - Fiona E. Scott AU - Cameron Durrant AU - Andrew M. Scott PY - 2026 JO - Molecular Cancer Therapeutics DO - 10.1158/1535-7163.mct-25-1492 UR - https://doi.org/10.1158/1535-7163.mct-25-1492 ER -
APA
Janes, P. W., Vail, M. E., Allen, S., Arora, S., Cao, Z., Fujii, T., Matsuda, Y., Chionh, F., Scott, F. E., Durrant, C., & Scott, A. M. (2026). Novel antibody-drug conjugates targeting EphA3 in tumours and the tumour microenvironment. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-25-1492
Source records
- crossref · retrieved 2026-11-04T20:32:58.424Z